Author: oncologs.com

Milan, Italy: The vast majority of young patients given a low-dose boost of radiotherapy to the site where their breast cancer was removed in addition to whole breast radiotherapy, remained free of local recurrence after ten years, according to results of the ‘Young boost trial’

Milan, Italy: A team of international researchers have developed an artificial intelligence (AI) tool that can predict which breast cancer patients may be at risk of side effects after surgery and radiotherapy. Credit: Dr Tim Rattay Milan, Italy: A team of international researchers have developed

IRVINE, CA, March 20, 2024 –The Pediatric Cancer Research Foundation (PCRF), a nonprofit focused on transforming pediatric cancer care by funding research breakthroughs, today announced the expansion of its leadership team. Executive Director Jeri Wilson, who has led the organization for 12 years, will step

Repairing patients’ dura more durably Credit: Peter Allen, Ryan Allen, and James C. Weaver. SEAS/MIT/Wyss Repairing patients’ dura more durably Highly adhesive and mechanically strong Dural Tough Adhesive addresses multiple limitations in the repair of the dural membrane lining the brain and spinal cord after

Traditionally, therapies combining DNA-damaging agents and STING agonists have shown potential in treating cancer by enhancing immune response and reshaping the tumor microenvironment. However, until now, creating a single molecular entity housing both agents remained elusive. Credit: ©Science China Press Traditionally, therapies combining DNA-damaging agents

Scientists from Universidad Carlos III de Madrid (UC3M) and Johns Hopkins University (JHU), in the USA, have analyzed the growth of breast tumors from a biomechanical perspective and have created a computational model that simulates the invasion process of cancer cells, depending on the characteristics

Researchers at Fred Hutchinson Cancer Center have found that a specific subtype of a microbe commonly found in the mouth is able to travel to the gut and grow within colorectal cancer tumors. This microbe is also a culprit for driving cancer progression and leads

Imagine being able to count the different types of blood cells being formed inside the tiny bones of a mouse and pinpointing the strings and clusters of cells within the bone marrow that are responsible for producing specific types of blood cells. Credit: Nature and

The Advanced Research Projects Agency for Health (ARPA-H) has appointed Etta D. Pisano, MD, FACR, senior portfolio lead, to build the agency’s clinical trial portfolio and lead the ARPA-H Advancing Clinical Trials Readiness Initiative under ARPA-H Resilient Systems Mission Office Director Jennifer Roberts. Credit: N/A The

MIAMI, FLORIDA (March 20, 2024) – Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have received two new three-year, $1 million grants from the U.S. Department of Defense to study endometrial cancer in Black women. Credit: Photos by